{"id":555262,"date":"2026-06-16T21:44:54","date_gmt":"2026-06-16T19:44:54","guid":{"rendered":"https:\/\/medizinonline.com\/evaluaciones-de-progreso-basadas-en-datos-actuales-a-largo-plazo-y-del-mundo-real\/"},"modified":"2026-04-23T16:28:11","modified_gmt":"2026-04-23T14:28:11","slug":"evaluaciones-de-progreso-basadas-en-datos-actuales-a-largo-plazo-y-del-mundo-real","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/evaluaciones-de-progreso-basadas-en-datos-actuales-a-largo-plazo-y-del-mundo-real\/","title":{"rendered":"Evaluaciones de progreso basadas en datos actuales a largo plazo y del mundo real"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>En la actualidad se dispone de un amplio espectro de agentes sist\u00e9micos para el tratamiento de la psoriasis de moderada a grave. En el congreso DDG de este a\u00f1o &#8220;Dermatolog\u00eda compacta + pr\u00e1ctica&#8221; se presentaron diversos estudios sobre los biol\u00f3gicos ixekizumab, bimekizumab y risankizumab, as\u00ed como sobre el inhibidor de la tirosina quinasa 2 (TYK2) deucravacitinib, entre otros, centrados en la evaluaci\u00f3n de los efectos terap\u00e9uticos a largo plazo y los resultados del tratamiento en la vida cotidiana.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fevaluaciones-de-progreso-basadas-en-datos-actuales-a-largo-plazo-y-del-mundo-real%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>En la actualidad se dispone de un amplio espectro de agentes sist\u00e9micos para el tratamiento de la psoriasis de moderada a grave. En el congreso DDG de este a\u00f1o &#8220;Dermatolog\u00eda&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fevaluaciones-de-progreso-basadas-en-datos-actuales-a-largo-plazo-y-del-mundo-real%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555263,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Psoriasis: terapia con biol\u00f3gicos y TYK-2-i","footnotes":""},"category":[11552,11310,11483,11475,11408,11451],"tags":[27129,12425,66184,81450,91654,12603,13983,91656,26525,91655],"powerkit_post_featured":[],"class_list":["post-555262","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-dermatologia-y-venereologia","category-el-congreso-informa","category-estudios","category-farmacologia-y-toxicologia","category-reumatologia","tag-bimekizumab-es","tag-biologicos-es","tag-deucravacitinib-es","tag-efectos-terapeuticos","tag-inhibidor-de-la-tirosina-quinasa-2-tyk2","tag-ixekizumab-es","tag-psoriasis-es-2","tag-resultados-del-tratamiento","tag-risankizumab-es","tag-tyk-2-i","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-12 10:30:01","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=555262"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555262\/revisions"}],"predecessor-version":[{"id":555264,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555262\/revisions\/555264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/555263"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=555262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=555262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=555262"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=555262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}